Baig, Hassam <br/><br/>
Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Oct 2019 
 - 1576-1585 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155218799859  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Febrile Neutropenia--prevention & control<br/>Female<br/>Filgrastim--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Polyethylene Glycols--therapeutic use<br/>Risk Factors<br/>Young Adult